Skip to main content
. 2023 Mar 8;14:1100007. doi: 10.3389/fendo.2023.1100007

Table 3.

Summary of treatment options in male adult affected by Isolated Hypogonadotropic Hypogonadism.

ADULT MALE HYPOGONADISM PROs CONTRAs
Testosterone enanthate, cypionate or mixture of esters 150-250 mg IM every 2-4 weeks Titrating dose based on clinical signs and symptoms, serum testosterone levels Self-injection
Easily available
Higher risk of erythrocytosis
Frequent serum testosterone peaks
Frequent injections
Testosterone undecanoate 750-1000 mg every 10-14 weeks Longer interval injections
Stable serum testosterone levels
injection by a health care provider
risk of pulmonary oil microembolism
Testosterone gel 40 mg-80 mg/daily Easy avoidable side effects
Non invasive
Mimics physiology
Daily administration
Skin irritation
Possible skin to skin transfer of therapy
Testosterone patch 2.5–5 mg/day Mimics physiology Skin irritation, Possible issues with frequent showering or certain lifestyle
Oral testosterone Undecanoate testosterone 158–396 mg twice daily Oral administration Daily multiple doses; need lipid rich meals; gastrointestinal side effects; hypertension
Intranasal testosterone 11 mg twice/die Easy to administer Sense of taste alteration
Testosterone pellets 75 mg pellets, 3-4 every 4-6 months Easier compliance Risk of local side effects (extrusion, fibrosis, infection)
Higher cost
ADULT SPERMATOGENESIS INDUCTION
Gonadotropins Starting dose: hCG 500 UI SC thrice/week
+ FSH 75-150 UI thrice/week
Titrating dose: - hCG increase based on serum testosterone
- FSH increase based on serum FSH and sperm count
Self-injections Require optimal compliance
Need frequent injections
Pulsatile GnRH SC pump: 25 ng/kg per pulse every 120 min Dose e adapted based on serum testosterone levels Most physiological Not easily available
Pituitary resistance (rare)

Adapted from Young et al., 2019 and Nordenstrom et al., 2022.

SC, subcutaneous; IM, intramuscular; hCG, Human chorionic gonadotropin; FSH, Follicle stimulating hormone.